<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Aeolus Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals
    Invest Now

    About Aeolus Pharmaceuticals, Inc.

    Aeolus Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on developing a platform of compounds for use in biodefense, fibrosis, oncology, infectious disease and diseases of the central nervous system.

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      Start Engine
    • RAISED AMOUNT
      $18,500,000
    • PRE-MONEY EVAULATION
      $794,000.00
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      John L. McManus
    • FOUNDED
      1994
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    ReWalk Robotics Ltd.

    ReWalk Robotics Ltd.

    ReWalk Robotics (Nasdaq: RWLK) is an innovative medical device company. We design,...

    ReWalk Robotics (Nasdaq: RWLK) is an innovative...

    Filing Type:    PU
    Second Sight Medical Products, Inc.

    Second Sight Medical Products, Inc.

    The recognized global leader in neuromodulation devices to treat blindness, the co...

    The recognized global leader in neuromodulation...

    Filing Type:    PU
    Halozyme Therapeutics, Inc.

    Halozyme Therapeutics, Inc.

    Halozyme is a clinical-stage biotechnology company focused on developing and comme...

    Halozyme is a clinical-stage biotechnology comp...

    Filing Type:    PU
    Robovet Corporation

    Robovet Corporation

    Robovet Corporation has developed a new MR imaging technology that can also help t...

    Robovet Corporation has developed a new MR imag...

    Amount Raised:    $136,889.00
    Fundraising Status:    EC
    Filing Type:    CF
    Mighty Health Co.

    Mighty Health Co.

    It was the middle of 2016 when we discovered that CBD could make a big difference ...

    It was the middle of 2016 when we discovered th...

    Fundraising Status:    EC
    Filing Type:    CF
    Kura Oncology, Inc.

    Kura Oncology, Inc.

    We are a clinical-stage biopharmaceutical company committed to realizing the promi...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    EyePoint Pharmaceuticals, Inc.

    EyePoint Pharmaceuticals, Inc.

    EyePoint Pharmaceuticals, Inc. is a specialty biopharmaceutical company committed ...

    EyePoint Pharmaceuticals, Inc. is a specialty b...

    Filing Type:    PU
    Verastem, Inc.

    Verastem, Inc.

    Verastem Oncology (Nasdaq: VSTM) is a commercial biopharmaceutical company committ...

    Verastem Oncology (Nasdaq: VSTM) is a commercia...

    Filing Type:    PU
    Galmed Pharmaceuticals Ltd.

    Galmed Pharmaceuticals Ltd.

    Galmed is a clinical-stage biopharmaceutical company focused on the development of...

    Galmed is a clinical-stage biopharmaceutical co...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.